You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report
|
|---|---|
| Published in |
Journal of Medical Case Reports, September 2014
|
| DOI | 10.1186/1752-1947-8-295 |
| Pubmed ID | |
| Authors |
Giovanni Caocci, Marianna Greco, Giorgio La Nasa |
| Abstract |
Although there is a considerable amount of data in the literature on safe discontinuation of first-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia, little is known about discontinuation of second-generation tyrosine kinase inhibitor therapy. Most previous studies have been focused on dasatinib, and the few cases of nilotinib withdrawal that have been reported had a median follow-up of 12 months. To the best of our knowledge, the present report is the first to describe nilotinib withdrawal with 30 months of follow-up. |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 9 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 2 | 22% |
| Student > Postgraduate | 2 | 22% |
| Student > Doctoral Student | 1 | 11% |
| Researcher | 1 | 11% |
| Other | 1 | 11% |
| Other | 0 | 0% |
| Unknown | 2 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 44% |
| Agricultural and Biological Sciences | 3 | 33% |
| Unknown | 2 | 22% |